It is our great pleasure to meet you through the March 2014 edition of Oviya MedSafe’s newsletter, soon after our return from a successful trip to the United Kingdom to exhibit Oviya MedSafe’s pharmacovigilance capabilities at the 6th Pharmacovigilance 2014 conference organized by Virtue Insight at London on March 4th and 5th.
Our team also had the opportunity to visit DUPHAT 2014 – Dubai International Pharmaceuticals and Technologies Conference and Exhibition 2014, which was conducted at Dubai from March 10th to 12th, on our way back. We thank all our colleagues who visited us at our stall in the London conference and those who took the time to meet us at the Dubai exhibition. The two weeks of travel have taught Oviya MedSafe quite a lot about both these markets.
As we venture into our third year of life with your heartfelt wishes, we are glad to share with you some of the moments of our enjoyment as a team, on account of Oviya MedSafe’s Second Anniversary which was celebrated at Hotel Heritage Inn, Coimbatore on 23-Feb-2014. Please click here to view the pictures of the event. Kindly share your comments and likes. In this year, we aspire to strategically expand our drug safety operations through various modes to serve more and more clients across the globe by offering both end-to-end pharmacovigilance support and standalone drug safety services to pharmaceutical companies and other marketing authorization holders, as appropriate.
We are proud to mention that an article titled “Gearing up for a Pharmacovigilance Audit Using a Risk Based Approach” which I authored with inputs from my colleagues Gayathri Subramani and Ganesan Ramakrishnan, has been published in the February 2014 edition of the popular pharmaceutical industry magazine Pharma Bio World. We are happy to share with you the article for online reading and for download in PDF format. We look forward to your feedback on the article which you can e-mail to us. We hope this article will be useful for all pharmaceutical companies in which the pharmacovigilance systems are evolving and in those whose systems need to be audited.
As you might know, I recently co-ordinated the conduct of a Continuing Medical Education Programme in Pharmacovigilance for Medical Practitioners, organized by the Indian Pharmacopoeia Commission (IPC), Ghaziabad – the National Coordination Centre (NCC) for the Pharmacovigilance Programme of India (PvPI), a Government of India initiative under the Ministry of Health & Family Welfare. The CME was organized by the IPC in technical collaboration with the Indian Medical Association Tamil Nadu State Branch, on Saturday 22-Feb-2014 at Chennai, India. The programme was quite successful and was reported in detail in popular pharmaceutical industry news portals Express Pharma and Pharmabiz. In fact, Pharmabiz did even a detailed pre-event coverage of the programme. The photos clicked during the event can be viewed by clicking here. Please feel free to share your comments and thoughts on these photographs.
Last but not the least, we would like to inform you that we will be in Mumbai for the “Conference on Pharmacovigilance & Drug Safety – A New Era” organized by the Drug Information Association (DIA) on March 21st and 22nd, 2014 at Sci-Tech Centre 7, Prabhatnagar, Jogeshwari (W), Mumbai 400 102. We consider this a great chance to network with colleagues from all over the world and are also keen to meet prospective clients at Mumbai interested to discuss business opportunities with Oviya MedSafe. Please contact us with your thoughts beforehand so that we can ensure that enough time is allotted for our scheduled meetings.
We thank you for your patient reading and look forward to meeting you at Mumbai on 21st and 22nd March 2014.
With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA
Managing Director & CEO,
Oviya MedSafe Pvt. Ltd.
Pharmacovigilance Consulting & Drug Safety Services
2nd Floor, KTVR Gardens,
220a-3, Marudha Konar Road,
Coimbatore – 641 025.
Tamil Nadu, India.
Office Mobile: +91-94422-25311
Office Phone: +91-422-2444442